tradingkey.logo

Bruker Corp

BRKR
41.930USD
+0.890+2.17%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
6.35BMarktkapitalisierung
VerlustKGV TTM

Bruker Corp

41.930
+0.890+2.17%

mehr Informationen über Bruker Corp Unternehmen

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp Informationen

BörsenkürzelBRKR
Name des UnternehmensBruker Corp
IPO-datumAug 04, 2000
CEOPrause (Burkhard A)
Anzahl der mitarbeiter11396
WertpapierartOrdinary Share
GeschäftsjahresendeAug 04
Addresse40 Manning Rd
StadtBILLERICA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01821-3915
Telefon19786633660
Websitehttps://www.bruker.com/
BörsenkürzelBRKR
IPO-datumAug 04, 2000
CEOPrause (Burkhard A)

Führungskräfte von Bruker Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+31932.00%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
--
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+4972.00%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+20621.00%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+9282.00%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+3767.00%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-921.00%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-921.00%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
14.72K
+765.00%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-921.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+31932.00%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
--
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
85.88K
+4972.00%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+20621.00%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+9282.00%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
31.91K
+3767.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
691.10M
80.31%
Product And Service Other
169.40M
19.69%
Service and other revenue
169.40M
19.69%
Nach RegionUSD
Name
Umsatz
Anteil
Rest of Europe
241.20M
28.03%
United States
226.00M
26.26%
Rest of Asia Pacific
130.70M
15.19%
China
121.80M
14.15%
Germany
71.30M
8.29%
Other
69.50M
8.08%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product
691.10M
80.31%
Product And Service Other
169.40M
19.69%
Service and other revenue
169.40M
19.69%

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.74%
Pallas Capital Advisors LLC
6.24%
Andere
43.60%
Aktionäre
Aktionäre
Anteil
Laukien (Frank H)
26.60%
Orbis Investment Management Ltd.
9.31%
Fidelity Management & Research Company LLC
7.52%
The Vanguard Group, Inc.
6.74%
Pallas Capital Advisors LLC
6.24%
Andere
43.60%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
51.09%
Individual Investor
31.97%
Investment Advisor/Hedge Fund
25.89%
Hedge Fund
8.24%
Research Firm
2.61%
Pension Fund
1.15%
Sovereign Wealth Fund
0.76%
Bank and Trust
0.34%
Insurance Company
0.21%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
887
137.27M
94.12%
+111.45K
2025Q3
908
137.16M
94.45%
+8.73M
2025Q2
904
127.18M
89.58%
+1.13M
2025Q1
886
125.13M
85.85%
-5.11M
2024Q4
855
125.47M
82.99%
+4.02M
2024Q3
812
120.93M
80.76%
+2.25M
2024Q2
782
118.65M
76.64%
+5.15M
2024Q1
766
113.09M
82.81%
-916.64K
2023Q4
748
112.27M
83.16%
-472.55K
2023Q3
723
112.40M
83.64%
-8.12M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Laukien (Frank H)
40.41M
26.6%
+31.93K
+0.08%
Aug 15, 2025
Orbis Investment Management Ltd.
14.15M
9.31%
+9.47M
+202.38%
Sep 30, 2025
Fidelity Management & Research Company LLC
11.42M
7.52%
+3.95M
+52.90%
Sep 30, 2025
The Vanguard Group, Inc.
10.38M
6.83%
-23.67K
-0.23%
Sep 30, 2025
Pallas Capital Advisors LLC
9.48M
6.24%
-20.70K
-0.22%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.22M
6.07%
-179.94K
-1.91%
Sep 30, 2025
Laukien (Joerg C)
7.52M
4.95%
--
--
Apr 01, 2025
T. Rowe Price Investment Management, Inc.
6.38M
4.2%
-5.05M
-44.19%
Sep 30, 2025
State Street Investment Management (US)
3.74M
2.46%
-44.57K
-1.18%
Sep 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
3.17M
2.08%
+1.66M
+110.32%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust NYSE Arca Biotechnology Index Fund
3.71%
ProShares Nanotechnology ETF
3.34%
State Street SPDR S&P Kensho Future Security ETF
1.27%
Ballast Small/Mid Cap ETF
1.13%
AB Disruptors ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
0.57%
iShares Health Innovation Active ETF
0.4%
iShares Biotechnology ETF
0.36%
JPMorgan Active Small Cap Value ETF
0.31%
Mehr Anzeigen
First Trust NYSE Arca Biotechnology Index Fund
Anteil3.71%
ProShares Nanotechnology ETF
Anteil3.34%
State Street SPDR S&P Kensho Future Security ETF
Anteil1.27%
Ballast Small/Mid Cap ETF
Anteil1.13%
AB Disruptors ETF
Anteil0.63%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.61%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.57%
iShares Health Innovation Active ETF
Anteil0.4%
iShares Biotechnology ETF
Anteil0.36%
JPMorgan Active Small Cap Value ETF
Anteil0.31%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 113.60M USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 04, 2025
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025
Dec 08, 2025
Jan 02, 2026
Dec 08, 2025
Aug 12, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025
Sep 23, 2025
Oct 03, 2025
Sep 23, 2025
May 15, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jun 27, 2025
Jun 16, 2025
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
Mehr Anzeigen

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI